3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
10
Fallopian Tube Neoplasms
7
Sarcoma
3
Sarcoma, Ewing
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Fallopian Tube Mucinous Adenocarcinoma
1
Dermatofibrosarcoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Magnetic Resonance Spectroscopy
2
tazemetostat
1
selinexor
1
pazopanib
1
fludarabine phosphate
1
fludarabine
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Nivolumab
1
Mesna
1
Ipilimumab
1
Ifosfamide
1
Doxorubicin
1
Cyclophosphamide
1
CTLA-4 Antigen
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.